Comments
Loading...

Iovance Biotherapeutics

IOVANASDAQ
Logo brought to you by Benzinga Data
$10.35
0.181.77%
At Close: -
$10.41
0.060.58%
After Hours: 7:57 PM EDT
15 minutes delayed
Consensus Rating1
Buy
Highest Price Target1
$34.00
Lowest Price Target1
$6.00
Consensus Price Target1
$21.44

Iovance Biotherapeutics (NASDAQ:IOVA) Stock, Analyst Ratings, Price Targets, Forecasts

Iovance Biotherapeutics Inc has a consensus price target of $21.44 based on the ratings of 17 analysts. The high is $34 issued by Chardan Capital on February 20, 2024. The low is $6 issued by Goldman Sachs on December 9, 2022. The 3 most-recent analyst ratings were released by HC Wainwright & Co., Piper Sandler, and HC Wainwright & Co. on August 12, 2024, July 29, 2024, and June 28, 2024, respectively. With an average price target of $24.67 between HC Wainwright & Co., Piper Sandler, and HC Wainwright & Co., there's an implied 136.95% upside for Iovance Biotherapeutics Inc from these most-recent analyst ratings.

Analyst Trends and Forecast
0
0
0
0
May
0
0
0
0
Jun
1
Jul
0
0
0
0
Aug
Buy
Hold
Sell
Strong Sell
Analyst Rating and Forecast
12345
3.8
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell

Analyst Firms Making Recommendations1

HC Wainwright & Co.
Piper Sandler
JMP Securities
Truist Securities
Wells Fargo

1calculated from analyst ratings

Analyst Ratings for Iovance Biotherapeutics

Data brought to you by Benzinga APIs

FAQ

Q

What is the target price for Iovance Biotherapeutics (IOVA) stock?

A

The latest price target for Iovance Biotherapeutics (NASDAQ:IOVA) was reported by HC Wainwright & Co. on August 12, 2024. The analyst firm set a price target for $32.00 expecting IOVA to rise to within 12 months (a possible 207.40% upside). 25 analyst firms have reported ratings in the last year.

Q

What is the most recent analyst rating for Iovance Biotherapeutics (IOVA)?

A

The latest analyst rating for Iovance Biotherapeutics (NASDAQ:IOVA) was provided by HC Wainwright & Co., and Iovance Biotherapeutics reiterated their buy rating.

Q

When was the last upgrade for Iovance Biotherapeutics (IOVA)?

A

The last upgrade for Iovance Biotherapeutics Inc happened on May 30, 2023 when Wells Fargo raised their price target to $17. Wells Fargo previously had an equal-weight for Iovance Biotherapeutics Inc.

Q

When was the last downgrade for Iovance Biotherapeutics (IOVA)?

A

The last downgrade for Iovance Biotherapeutics Inc happened on July 29, 2024 when Piper Sandler changed their price target from $19 to $10 for Iovance Biotherapeutics Inc.

Q

When is the next analyst rating going to be posted or updated for Iovance Biotherapeutics (IOVA)?

A

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Iovance Biotherapeutics, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Iovance Biotherapeutics was filed on August 12, 2024 so you should expect the next rating to be made available sometime around August 12, 2025.

Q

Is the Analyst Rating Iovance Biotherapeutics (IOVA) correct?

A

While ratings are subjective and will change, the latest Iovance Biotherapeutics (IOVA) rating was a reiterated with a price target of $32.00 to $32.00. The current price Iovance Biotherapeutics (IOVA) is trading at is $10.41, which is out of the analyst’s predicted range.

Browse analyst ratings and price targets on all stocks.

People Also Watch